5959 Cornerstone Court West
ImpediMed develops bioimpedance devices with a focus on medical applications in the fluid status area. Primary to this is the L-Dex U400 which measures extracellular fluid differences in the limbs for unilateral lymphedema.
The company is pioneering the use of next generation bioimpedance technology in BIS (Bioimpedance Spectroscopy).
Founder: Mel Bridges
CEO: Richard Carreon
Please click here for ImpediMed job opportunities.